AVEO Pharmaceuticals (NASDAQ:AVEO) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
AVEO Pharmaceuticals missed estimated earnings by 20.0%, reporting an EPS of $-0.3 versus an estimate of $-0.25.
Revenue was up $19.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.08 which was followed by a 8.5% increase in the share price the next day.
Here's a look at AVEO Pharmaceuticals's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.29 | -0.36 | -0.45 | -0.55 |
| EPS Actual | -0.21 | -0.30 | -0.40 | -0.81 |
| Revenue Estimate | 17.93M | 13.80M | 8.94M | 1.01M |
| Revenue Actual | 17.65M | 15.17M | 7.56M | 1.92M |
To track all earnings releases for AVEO Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
